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Titanium dioxide nanoparticles (nanoTiO2) are
used in various applications including in paints.
NanoTiO2 inhalation may induce pulmonary toxic-
ity and systemic effects. However, the underlying
molecular mechanisms are poorly understood. In
this study, the effects of inhaled surface-coated
nanoTiO2 on pulmonary global messenger RNA
(mRNA) and microRNA (miRNA) expression in
mouse were characterized to provide insight into
the molecular response. Female C57BL/6BomTac
mice were exposed for 1 hr daily to 42.4 6 2.9
(SEM) mg surface-coated nanoTiO2/m
3 for 11 con-
secutive days by inhalation and were sacriﬁced 5
days following the last exposure. Physicochemical
properties of the particles were determined. Pulmo-
nary response to nanoTiO2 was characterized
using DNA microarrays and pathway-speciﬁc PCR
arrays and related to data on pulmonary inﬂamma-
tion from bronchial lavages. NanoTiO2 exposure
resulted in increased levels of mRNA for acute
phase markers serum amyloid A-1 (Saa1) and se-
rum amyloid A-3 (Saa3), several C-X-C and C-C
motif chemokines, and cytokine tumor necrosis fac-
tor genes. Protein analysis of Saa1 and 3 showed
selective upregulation of Saa3 in lung tissues. Six-
teen miRNAs were induced by more than 1.2-fold
(adjusted P-value < 0.05) following exposure. Real
time polymerase chain reaction conﬁrmed the up-
regulation of miR-1, miR-449a and revealed dra-
matic induction of miR-135b (60-fold). Thus, inhala-
tion of surface-coated nanoTiO2 results in changes
in the expression of genes associated with acute
phase, inﬂammation and immune response 5 days
post exposure with concomitant changes in several
miRNAs. The role of these miRNAs in pulmonary
response to inhaled particles is unknown and war-
rants further research. Environ. Mol. Mutagen.
52:425–439, 2011. V V C 2011 Wiley-Liss, Inc.
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Environmental andMolecularMutagenesis52:425^439 (2011)BACKGROUND
Rapid developments in nanotechnology are resulting in
increased use and potential release of a variety of engi-
neered nanomaterials into the workplace and environment.
Nanoparticles (NPs) are particles with a diameter less
than 100 nm along at least one dimension and exhibit
new or enhanced size-associated properties compared
with larger particles of the same material. The large sur-
face area, unique surface chemistry, and reactivity of NPs
pose a unique challenge in assessing their effects on bio-
logical systems. Consequently, there is little knowledge of
the molecular mechanisms leading to toxic effects follow-
ing exposure to the diverse types of NPs, and there is no
accepted framework for risk assessment of NP exposure
[Oberdorster et al., 2005a,b; Borm et al., 2006].
Titanium dioxide nano particles (nanoTiO2) are poorly
soluble and were originally considered to be physiologi-
cally inert, posing little risk to human health. However, the
International Agency for Research on Cancer has recently
classiﬁed pigment-grade titanium dioxide as a group 2B
carcinogen [IARC, Feb. 2006]. NanoTiO2 has also been
listed as a high priority NP by the Organization for Eco-
nomic Cooperation and Development steering group for
test guidelines. NanoTiO2 are widely used in paints, paper,
plastics, ceramics, and cosmetic sunscreens. Thus, there is
potential for human exposure to nanoTiO2 occupationally
or through release from consumer products. As a result,
there is an urgent need for experimental investigations on
the biological effects of various types of NPs to increase
our understanding of the mechanisms of NP action and es-
tablish safe regulatory guidelines for human exposure.
Studies have demonstrated that nanoTiO2 causes cellular
damage in exposed rodents. For example, chronic exposure to
high doses of nanoTiO2 by inhalation causes bronchoalveolar
hyperplasia, metaplasia, pulmonary ﬁbrosis, and tumor forma-
tion in rats [Lee et al., 1985; Heinrich et al., 1995], possibly
resulting from impaired particle clearance [Warheit et al.,
1997; Cullen et al., 2000]; lower doses cause lung inﬂamma-
tion in mice [Dankovic et al., 2007]. A single intratracheal
dose of nanoTiO2 can disrupt alveolar septa and induce em-
physema-like changes in mouse lungs [Chen et al., 2006].
Particle accumulation in lungs and interstitial pneumonia
associated with alveolar septal thickening results following in-
traperitoneal injection of nanoTiO2 in mice [Chen et al.,
2009]. A multispecies, subchronic, inhalation study demon-
strated similar inﬂammatory responses, lung burdens, and pul-
monary overload in both mice and rats exposed at high doses
[Bermudez et al., 2004]. NanoTiO2 is also cytotoxic and
causes DNA damage and mutation in various animal and
human cell lines [Rahman et al., 2002; Bermudez et al., 2004;
Sayes et al., 2006; Warheit et al., 2006; Wang et al., 2007].
To increase its stability in paints, lotion, or creams,
nanoTiO2 in general are surface coated with silica, alu-
mina, or other polymers. Surface-coated nanoTiO2 in
sunscreen lotions is expected to reduce its photoactivity.
However, surface coatings and functionalization play a
major role in nanoTiO2-induced toxicity. For instance,
mice challenged with nanoTiO2 coated with silica exhib-
ited signiﬁcantly larger inﬂammatory responses than mice
challenged with uncoated nanoTiO2 or silica alone [Rossi
et al., 2010]. Similarly, vanadium pentoxide-coated ana-
tase nanoTiO2 particles induced more cytotoxicity and
genotoxicity than natural anatase [Bhattacharya et al.,
2008]. Therefore, nanoTiO2 toxicity is enhanced by sur-
face modiﬁcations of the particles. However, it is unclear
what changes arise at the molecular level that lead to dif-
ferences in the toxicity induced by uncoated nanoTiO2
relative to particles that are surface modiﬁed.
Genomic analyses provide a means to analyze the entire
transcriptome of cells or tissues [Mei et al., 2010]. Early
changes in critical pathways may be used to predict eventual
health outcomes as well as derive the molecular mechanisms
leading to toxicity [Hanahan and Weinberg, 2000; Bhatta-
charjee et al., 2001; Golpon et al., 2004; Ning et al., 2004;
Spira et al., 2004; Granville and Dennis, 2005]. However,
mRNA expression does not always correlate with related pro-
tein abundance and activity, as mRNA and proteins may be
post-transcriptionally regulated. Small noncoding RNAs
known as microRNAs (miRNAs) have recently been found
to play a central role in the regulation of gene expression and
protein translation. MiRNAs are typically 21–25 nucleotides
in length and function in translational repression or mRNA
degradation via the RNA interference pathway [Kim et al.,
2009; Winter et al., 2009]. MiRNAs are also thought to play
an important role in the maintenance of chromatin structure
and are therefore critical mediators of gene expression and
genome stability [Guil and Esteller, 2009]. MiRNAs are
involved in numerous biological processes including apopto-
sis [Lynam-Lennon et al., 2009], cell cycle progression
[Carleton et al., 2007; Bueno et al., 2008], development
(reviewed in [Sun and Tsao, 2008]), and immune response
(reviewed in [Tsitsiou and Lindsay, 2009]). Aberrant miRNA
expression has been found in several human diseases
(reviewed in [Wang et al., 2008]), and many cancers express
unique miRNA signatures [Croce, 2009; Garzon et al., 2009].
As such, disruption of miRNA expression is now being
widely investigated and various techniques have been devel-
oped for this purpose (reviewed in [Kong et al., 2009]).
We have recently investigated the developmental and
neurological effects of surface-coated nanoTiO2 particles
[Hougaard et al., 2010]. We also reported pulmonary
inﬂammation in nonpregnant adult female mice exposed
by inhalation to a low, biologically relevant dose of rutile
nanoTiO2 particles that were surface modiﬁed and coated
[Hougaard et al., 2010]. In this study, we apply DNA
microarrays, pathway-speciﬁc real-time polymerase chain
reaction (RT-PCR) arrays, focussed RT-PCR, and protein
analysis to characterize the molecular changes associated
with the observed pulmonary inﬂammation in the same
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TiO2 particles from the above study.
MATERIALS ANDMETHODS
Material,Animal Handling,and TissueCollection
This study used UV-titan L181 with particle size of 20 nm (Kemira,
Pori, Finland) enriched in rutile and modiﬁed with amounts of zirco-
nium, silicon, aluminum, and coated with polyalcohol.
The study was conducted in parallel with a developmental toxicity
study and therefore the particle dose and the time point were selected
accordingly. Detailed information about animals, exposure, and exposure
monitoring is described by Hougaard et al. [2010]. Brieﬂy, 45 time-
mated, nulliparous, adult female C57BL/6BomTac mice were treated as
described by Hougaard et al. [2008] by whole-body inhalation to 42.4 6
2.9 (SEM) mg nanoTiO2/m
3 or to ﬁltered air for 1 hr/day for 11 days.
Seventeen (nine controls and eight exposed) of these animals did not
conceive (lack of pups and interuterine implantation sites) and were used
in this study as exposed adult females.
Animals were sacriﬁced by cardiac puncture 5 days after the last ex-
posure. Left lung and a section of the liver were sliced randomly into
portions and used for (a) total RNA extraction; (b) total RNA extraction
enriched with small RNAs; and (c) total protein extracts. Samples were
stored at 2808C until analysis. All procedures complied with EC Direc-
tive 86/609/EEC and Danish laws regulating experiments on animals
(permit 2006/561-1123).
MaterialCharacterization
Details of sample preparation and particle analysis are described in the
Supporting Information provided by Hougaard et al. [2010]. In brief, phys-
ical particle size, morphology, and general state of agglomeration/aggrega-
tion were determined by transmission electron microscope (TEM, Tecnai
G20, FEI Company, Hillsboro, OR). Crystalline phases and crystallite
sizes were determined by powder X-ray diffraction (XRD) with a Bruker
D8 Advance diffractometer equipped with a Lynxeye CCD detector
(Bruker AXS, Madison, WI 53711-5373). Results were obtained by Riet-
veld reﬁnement of the X-ray diffractograms using Bruker 10 TOPAS V4.1
software. Speciﬁc surface area was determined on a Quantachrome Auto-
sorp-1 (Quantachrome GmbH & Co. KG, Odelzhausen, Germany) using
multipoint Brunauer, Emmett, and Teller (BET) nitrogen adsorption
method after 1 hr degassing at 3008C. Analysis was completed according
to DIN ISO 9277 as a commercial service by Quantachrome GmbH & Co.
KG. Elemental composition was analyzed by X-ray Fluorescence analysis
on a Philips PW-2400 spectrometer as a commercial service by the Depart-
ment of Earth Sciences, University of Aarhus, Denmark.
ExposureMonitoring
The ﬁne particle exposure (<600 nm) was monitored using a GRIMM
Sequential (Stepping) Mobility Particle Sizer (SMPS, Model No. 5.521;
Serial No. 5LP 10209) connected to a GRIMM Condensation Particle
Counter (Model 5.400). The SMPS data sampling and calculations were
completed using the GRIMM software 5.477/02 v. 1.34 and operated in
the fast scan mode. Data were corrected for both Classiﬁer and CPC efﬁ-
ciency using the available software options. Particles were neutralized
using a 3.7 MBq Am-241 source (Model No. 5.521). Coarse particle ex-
posure (0.75 to > 15 lm) was measured using a GRIMM Dust Monitor
(Model 1.105) at a resolution of 6 sec. The Dust Monitor particle sizes
were subsequently recalculated to geometric means assuming an upper
channel cut point at 20 lm.
Titanium inTissue
Approximately 25–75 mg of lung tissue was weighed and digested in
concentrated nitric acid (PlasmaPure, SCP Science, Quebec, Canada) in
a microwave oven (Multiwave, Anton Paar, Graz, Austria), and titanium
content was determined by quadrupole-based inductively coupled plasma
mass spectrometer (ICPMS 7500ce, Agilent Technologies, Tokyo, Japan)
equipped with a collision/reaction cell (CRC). The limit of detection
(LOD) for titanium in tissues, based on three times the standard devia-
tion of repeated blank measurements, was estimated to be 0.2–5 mg/kg
depending on sample intake and dilution. Additional details are described
by Hougaard et al. [2010].
TotalRNA and MiRNAExtraction and Purification
Total RNA was isolated from the lung and the liver (n 5 8/group)
using TRIzol reagent (Invitrogen) and puriﬁed using RNeasy Mini Kit
(Qiagen). The mirVana miRNA Isolation Kit (Ambion, Streetsville, ON,
Canada) was used to prepare total RNA enriched with small RNA spe-
cies from randomly selected left lung sections. RNA quality was con-
ﬁrmed by UV spectrophotometry and using an Agilent bioanalyzer (Agi-
lent Technologies).
MicroarrayHybridization
Individual total RNA (250 ng) samples from eight mice per treatment
group (control or exposed) and universal reference total RNA (Strata-
gene) were used to synthesize double-stranded cDNA and cyanine la-
beled cRNA according to the manufacturer’s instructions (Agilent Linear
Ampliﬁcation Kits, Agilent Technologies). Experimental samples were
labeled with Cyanine 5-CTP and reference RNA with Cyanine 3-CTP
(Perkin-Elmer Life Sciences). Cyanine-labeled cRNA targets were in
vitro transcribed using T7 RNA polymerase, puriﬁed by RNeasy Mini
Kit (Qiagen) and were hybridized to Agilent mouse 4 3 44 oligonucleo-
tide microarrays (Agilent Technologies) at 608C overnight. Arrays were
washed and scanned on an Agilent G2505B scanner. Data were acquired
using Agilent Feature Extraction software version 9.5.3.1.
MiRNAExpressionProfiling
Freshly isolated individual total lung RNA samples from eight control
and eight treated samples were labeled using the Agilent miRNA Com-
plete Labeling and Hybridization Kit (Agilent Technologies). Brieﬂy,
100 ng of total RNA was dephosphorylated by incubation with calf in-
testinal phosphatase at 378C for 30 min, denatured using 100% DMSO
at 1008C for 5 min, then labeled with pCp-Cy3 using T4 ligase by incu-
bation at 168C for 1 hr. The labeled RNA samples were hybridized to an
individual array on 8 3 15K format Agilent mouse miRNA array slides.
Hybridizations were performed in SureHyb chambers (Agilent) at 558C
for 20 hrs. Arrays were washed, scanned at a resolution of 5 lm using
an Agilent G2505B scanner and data were acquired using Agilent Fea-
ture Extraction software version 9.5.3.1.
StatisticalAnalysis ofMicroarray Data
A reference design [Kerr, 2003; Kerr and Churchill, 2007] was used
to analyze gene expression microarray data. Data were normalized using
LOWESS in R [R-Development-Core-Team, 2004] and differential
expression was determined using MAANOVA [Wu et al., 2003]. The Fs
statistic [Cui et al., 2005] was used to test for treatment effects, and P-
values were estimated by the permutation method using residual shuf-
ﬂing, followed by adjustment for multiple comparisons using the false
discovery rate (FDR) approach [Hochberg, 1995]. Fold change calcula-
tions were based on the least-square means. Signiﬁcant genes were iden-
tiﬁed as having an adjusted P-value < 0.05 for any individual contrast.
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Nonbackground subtracted raw data were quantile normalized [Bolstad
et al., 2003]. Present calls were determined as signals that were >3
trimmed SDs above the trimmed mean of the (2)3 3 SLv1 probes on
the array. Probes with technical replicates for a miRNA were averaged
using the median signal intensity. Boxplots and cluster analyses were
used to identify potential outliers (poor quality chips). This quality con-
trol check resulted in the elimination of six arrays from the analysis.
Identiﬁcation of differentially expressed miRNA was carried out at the
probe level as well as the miRNA level. The MAANOVA model
included the sample identity as a random effect and the gene speciﬁc
variance estimate (F1 Test) was used to test for differences between the
control and treated samples. In this analysis, parametric P-values were
obtained and were then FDR corrected.
Real-TimePolymeraseChain Reaction
Microarray
Primers were designed using Beacon design 2.0 (Premier BioSoft
International). Approximately 2.5 lg of total RNA per sample was
reverse transcribed and RT-PCR was performed in duplicate using an
iCycler IQ real-time detection system (Bio-Rad). Threshold cycle values
were averaged. Gene expression levels were normalized to the GAPDH
and Hprt gene, which were stable on the DNA microarray. PCR efﬁ-
ciency was examined using the standard curve for each gene. Primer
speciﬁcity was assured by the melting curve for each gene. A Students’
t-test was used for statistical evaluation. A minimum of ﬁve samples/
treatment group were used.
MicroRNA
The Qiagen miScript PCR system was used. For each sample (n 5 5
per group), 1 lg of total RNA enriched with small RNA species was
polyadenylated and then converted to cDNA using an oligodT primer
with a universal tag and miScript Reverse Transcription mix. Real-time
PCR was performed in duplicate for each sample, using a primer com-
plementary to the universal tag and a miScript primer (Qiagen) speciﬁc
for each miRNA. Ampliﬁed product was detected using SYBR Green
and a CFX real-time detection system (Bio-Rad). Expression levels of
miRNAs were normalized to expression levels of small nuclear RNAs
RNU1A1 and RNU5A1. A Students’ t-test was used to statistically eval-
uate the data.
Pathway-Specific PCR Arrays
Approximately 800 ng of total RNA per sample (n 5 6/group) was
reverse transcribed using a RT
2 ﬁrst strand kit (SABiosciences
TM).
Reverse transcription and real-time PCR reactions were carried out using
RT
2 SYBR Green PCR Master Mix on 96-well PCR arrays designed for
the evaluation of mouse inﬂammatory cytokines and receptors (No.
PAMM-011D, SABiosciences
TM) using a CFX real-time Detection Sys-
tem (BioRad). Threshold cycle values were averaged. Relative gene
expression was determined according to the comparative Ct method and
normalized to the Hprt and b-actin housekeeping genes. Fold changes
were calculated using online PCR array data analysis software (SABio-
sciences
TM). Statistical signiﬁcance was calculated using the REST
method [Pfafﬂ et al., 2002].
PathwayAnalysis
Gene ontology was used to assign genes to functional categories in
DAVID [Huang da et al., 2009]. KEGG pathways were used to identify
speciﬁc biological pathways associated with the differentially expressed
genes. In addition, we also conducted pathway analyses using two pro-
grams we developed to perform gene set enrichment analysis in R. KEGG
gene sets were obtained using the mgug4121a.db R library. The ﬁrst
method is a rank-based test that takes into accounts the magnitude of the
intensity value as well as the correlation between genes within a speciﬁc
pathway. The advantage of this test is that no assumptions on distribution
or independence are made. Genes in a pathway are ranked within each ob-
servation and the average rank is calculated for each treatment. The dis-
tance between the two treatments is calculated. Permutation analysis is
used to obtain a P-value for each pathway (Table I in the manuscript). The
second method (Design-based test) utilizes Euclidean distance between
the estimated mean vector of two treatment groups as the test statistic. The
null distribution of the test statistic distance is obtained using bootstrap-
ping as described by Kerr and Churchill [2001]. The advantage of this
method is that the experimental design used in the study is accounted for.
PreparationofTissueProtein Extracts and Western
Blotting
A random section of the frozen left lung lobe was homogenized in
lysis buffer (5 M HEPES, pH 7.5, 5 M NaCl, 10% Glycerol, 1% Triton
X-100, 2 M EGTA, 1 M MgCl2, 0.5 M NaF, 0.2 M sodium pyrophos-
phate, protease inhibitor cocktail tablets (Roche Applied Science)) and
centrifuged. The supernatant was quantiﬁed for protein content using a
Bradford protein assay reagent kit (Bio-Rad).
Total lung protein extracts were immunoblotted on 14% SDS-PAGE
gels and analyzed using antibodies against Saa3 (Santa Cruz Biotechnol-
ogies). Membranes were stripped and reprobed with anti-actin antibody
for normalization. Band intensities were determined by averaging the
densitometric readings from three biological replicates of control and
treated samples from the same gel.
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TABLE I. Gene Set Enrichment Analysis
Pathway P value
Probe
aTotal
bChanging
Rank-based test
Complement and coagulation cascades 0.002 123 18
Hematopoietic cell lineage 0.002 253 13
Olfactory transduction 0.003 914 2
Pantothenate and CoA biosynthesis 0.008 26 1
Systemic lupus erythematosus 0.013 222 11
Cytokine-cytokine receptor interaction 0.018 652 33
gamma-Hexachlorocyclohexane degradation 0.021 27 3
Neuro active ligand-receptor interaction 0.041 421 3
Toll-like receptor signaling pathway 0.045 332 11
Design-based test
Cytokine-cytokine receptor interaction 0.001 652 33
Pantothenate and CoA biosynthesis 0.001 26 1
Hematopoietic cell lineage 0.006 253 13
Complement and coagulation cascades 0.011 123 18
Systemic lupus erythematosus 0.017 222 11
ABC transporters 0.018 87 2
Natural killer cell mediated cytotoxicity 0.018 334 13
T cell receptor signaling pathway 0.019 352 11
gamma-Hexachlorocyclohexane degradation 0.026 27 3
Fc epsilon RI signaling pathway 0.029 243 13
Asthma 0.032 87 3
Jak-STAT signaling pathway 0.032 390 10
Linoleic acid metabolism 0.041 53 6
aTotal indicates the total number of known probes in a given pathway.
bChanging indicates the number of probes changing in a given pathway
following the exposure.
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The Mouse SAA immunoassay (Invitrogen) was used to measure total
Saa1 in lung tissue homogenates. The assay was conducted according to
the manufacturer’s instructions. Brieﬂy, 100 ll of assay diluent and
known quantities of controls (0–5 lg/ml mouse SAA supplied by the
company) and individual samples (100 lg total tissue homogenates) in
50 ll of incubation buffer were loaded onto a microplate precoated with
mouse Saa1 speciﬁc antibody followed by addition of biotinylated sec-
ond monoclonal antibody. The plate was incubated at 378C for 1 hr
and unbound Saa1 was removed by washing. A streptavidin-HRP
enzyme was then added to each well and incubated for 30 min at room
temperature. Plates were washed to remove any unbound enzyme conju-
gate. One-hundred microliters of chromagen substrate solution was added
to each well and incubated in the dark for 30 min at room temperature.
The reaction was quenched by adding 100 ll of stop solution to individ-
ual wells. Optical Density for each well was determined at 450 nm using
a microtiter plate spectrophotometer.
For analysis of Saa2, an Enzyme Immunoassay kit (Life Diagnostics)
was used. One hundred micrograms of total protein from individual lung
homogenates and controls (reference standard Saa2 0–500 ng/ll, supplied
by the company) were loaded onto a plate precoated with anti-mouse Saa2
antibody along with horseradish peroxidase-conjugated polyclonal anti-
body. Plates were incubated for 1 hr at room temperature, wells were
washed and 100 ll of chromagen was added to each well. Following incu-
bation with chromagen for 20 min at room temperature, 100 ll of stop so-
lution was added and the optical density was read at 450 nm in a microtiter
plate reader. A minimum of 3 samples/treatment group were used.
RESULTS
Exposure and Particle Characterization
Mature female mice (n 5 9/controls, 8/treated) were
exposed for 1 hr per day for 11 consecutive days to 42.4
6 2.9 (SEM) mg/m
3 nanoTiO2 particles. Physicochemical
characteristics of the nanoTiO2 used in the study are pre-
sented in detail by Hougaard et al. [2010]. Brieﬂy, the
sample consisted of a rutile TiO2-based material, which
accounted for 70.8 wt% TiO2. The other major constitu-
ents were modiﬁers of SiO2 > Al2O3 > ZrO2 and 5.2
wt% polyalcohol coating. Mass spectrometric analyses
suggested that the polyalcohol consisted of a complex
mixture with 4, 6, or 8 carbon chain length. BET meas-
urements showed that the speciﬁc surface area was 107.7
m
2/g, which is slightly higher than what was reported by
the manufacturer (70 m
2/g). Transmission electron mi-
croscopy showed that the powder particles consisted of
aggregates and agglomerates of equidimensional to nee-
dle-shaped TiO2 crystals with particle size ranging from
less than 10 nm to more than 100 nm diameter. Rietveld
analysis of powder X-ray diffractograms revealed that the
average crystallite size of the TiO2 was 20.6 6 0.3 nm,
but an elongation was also determined.
The mice were exposed to 42.4 6 2.9 (SEM) mg nano-
TiO2/m
3 particles mass concentrations as indicated by peri-
odic ﬁlter measurements. The number of particles in the
exposure atmosphere was 1.70 6 0.20 3 10
6/cm
3 with
major particle sizes of  100 nm and 4 lm. About 80% of
the particles by number were between 40 and 200 nm with
a maximum size of 12 lm. However, the mass–size distri-
bution was dominated by micrometer-size particles. Sub-
100 nm size particles made up less than 1% of the mass.
The concentration of TiO2 particles in tissues was ana-
lyzed by ICPMS and showed 38 mg TiO2/kg in the lungs
of mice 5 days after the last exposure. The lungs of con-
trol mice did not contain TiO2. No TiO2 particles were
detected in the liver tissues of the exposed or control
mice [Hougaard et al., 2010].
BronchoalveolarLavageFluid Analysis
To assess inﬂammatory response to nanoTiO2 exposure
in mouse lungs, inﬂammatory cell counts were performed
on the bronchoalveolar lavage ﬂuid (BALF) as described
by Hougaard et al. [2010] and the response was reported
in detail by Hougaard et al. [2010]. Brieﬂy, the total num-
ber of cells in BALF from mice exposed to nanoTiO2
increased by 21% compared with mice exposed to air
only, a change that was not statistically signiﬁcant. The
percentage of neutrophils increased signiﬁcantly from 2%
in control (air exposed) mice to 43% in the nanoTiO2-
treated group (a 19-fold increase). However, the total
number of macrophages decreased from 87% in controls
to 49% in the treated group. There was a 6-fold increase
in lymphocytes in the treated group and no signiﬁcant
changes in the total number of eosinophils and epithelial
cells [Hougaard et al., 2010].
GeneExpression Analysis
MAANOVA analysis revealed 353 transcripts that were
differentially expressed (FDR—P-values < 0.05) com-
pared with matched controls. Of these, 53 had fold
changes >1.5 for exposed versus control (50 upregulated
and 3 downregulated) (full list in Additional File 1; File
1: Supporting Information Table S1). Complete microar-
ray data are available through the Gene Expression Omni-
bus at NCBI (http://www.ncbi.nlm.nih.gov/geo/), GSE
19487. A heatmap was generated using the Heatplus
library [Ploner, 2008] in R [R-Development-Core-Team,
2009] using the log2 of the relative intensities. Any tech-
nical probe replicates were averaged using the mean. Out-
liers were removed based on the cluster analysis of the
normalized log2 of the Cy3 and Cy5 channel. Hierarchi-
cal cluster analysis on differentially expressed genes
revealed that samples within a treatment group were clus-
tered together (Additional File 1; File 1: Supporting Infor-
mation Fig. S1). Thus, a clear treatment effect was found
as a result of exposure to nanoTiO2. The genes with
increased mRNA levels included the following: serum
amyloid A-3 (Saa3, 4.7-fold), chemokine (C-X-C motif)
ligand 5 (cxcl5, 4.4-fold), lymphocyte antigen 6 complex,
locus F (Ly6f, 4.3-fold), solute carrier family 26, member
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NADPH oxidase organizer 1 (Noxo1, 3.0-fold). Among
the genes with decreased mRNA levels, the largest
decrease was observed for calcium-dependent phospho-
lipid-binding protein, Copine5 (Cpne5, 2.1-fold). Real
time RT-PCR conﬁrmed the altered mRNA levels of se-
rum amyloid A 1(Saa1), Saa3, Noxo1, NADPH oxidase
activator 1 (Noxa1), matrix metallopeptidase 12
(Mmp12), and complement component 3 (C3) in the
exposed mice (Fig. 1A).
Gene ontology analysis was used to assign genes to func-
tional categories in DAVID [Huang da et al., 2009]. KEGG
pathways were used to identify speciﬁc biological pathways
associated with the differentially expressed genes. Pathway
enrichment analysis applied two programs using the mgu-
g4121a.db R library (Table I, rank-based test [Alvo et al.,
2010], and a design-based test). The major pathways that
were identiﬁed remained the same regardless of the method
applied. These included cytokine–cytokine receptor interac-
tion, metabolism, complement and coagulation cascade,
hematopoeitic cell lineage, biosynthesis of steroids, and
systemic lupus erythematosus.
InductionofAcute Phase ResponseReactants
NanoTiO2 exposure altered the expression of several
acute phase response genes (Table II) including Saa1 and 3.
Previous work has demonstrated that acute phase response
genes including Saa are induced in response to air pollution
and inhaled particulates [Pope et al., 2004; Ruckerl et al.,
2006]. Protein analysis was conducted to elucidate the role
of Saa genes in nanoTiO2-induced lung response. ELISA
analysis of total lung tissue homogenates could not detect
Saa2 in either treatment group (data not shown). A very
modest decrease (0.86-fold) in total Saa1 protein was
observed in the lung tissues of exposed mice (Additional
File 1; File 1: Supporting Information Fig. S2A), in contrast
to the gene expression results (Table II, 2.2-fold upregu-
lated). This observation may have been due to outlying val-
ues from two control mice (expressing high amounts of
Saa1 as indicated by the large error bars, Additional File 1;
File 1: Supporting Information Fig. S2A.). Alternatively,
Saa1 may be targeted post-transcriptionally by a miRNA
that is also induced in response to nanoTiO2. Western blot
analysis (no ELISA assay available) revealed a 2.2-fold
increase in total Saa3 protein in the nanoTiO2-treated group
relative to matched controls (Additional File 1; File 1: Sup-
porting Information Fig. S2B).
InductionofInflammatoryCytokines and Receptors
NanoTiO2 exposure resulted in increased mRNA levels
of genes associated with cytokine–cytokine receptor sig-
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TABLE II. List of all Acute Phase Response Genes Showing
Fold Changes Higher Than 1.2 in exposed mice
Acute phase reactants P value Fold change
a
Serum amyloid A1 0.00 2.24
Serum amyloid A3 0.00 4.71
Complement protein C3 0.00 1.37
Complement component
1, s (C1s)
0.00 1.28
Complement component
3a receptor 1 (C3ar1)
0.00 1.15
Complement component
1, q beta polypeptide (C1qb)
0.00 1.30
Complement component
1, r subcomponent (C1r)
0.00 1.31
Complement component
C1RB (C1rb)
0.00 1.21
Fibrinogen 0.01 2.05
Coagulation factor II (F2) 0.01 1.72
Mannose binding protein 0.02 1.70
Albumin 0.01 1.79
apoA1 0.01 1.51
apoAII 0.03 1.61
alpha2-HS glycoprotein 0.00 1.85
S100A8 (calgranulin A) 0.01 21.85
Serpina3n 0.00 1.37
Gene names in bold indicate FDR adjusted P value > 0.05.
aAverage fold change compared with matched controls.
Fig.1. Real time quantitative PCR validation of array results. A: Microar-
ray results. Data (n 5 5 mice/group, 6SEM) are presented as average fold
changes over matched controls (air exposed). Gene expression values were
normalized to internal reference gene GAPDH and Hprt. B: MicroRNA
array results. Data are presented as average fold changes over matched
controls (air exposed). (n 5 5 mice/group, 6SEM). Expression values
were normalized to small nuclear RNA RNU1A1. Numbers indicate fold
changes. * indicates signiﬁcant by Students’ t-test.
430 Halappanavaret al.naling and chemokine signaling pathways. These include
chemokine (C-X-C motif and C-C motif) ligands (cxcl5,
cxcl1 and cxcl12, ccl7, ccl9, ccl2, ccl17, ccl12, and
ccl19). We conﬁrmed the altered mRNA levels of these
genes using pathway-speciﬁc PCR arrays (mouse inﬂam-
matory cytokines and receptors; SABiosciences
TM)
containing 70 different cytokines and chemokines. Six
individual samples from the control and treatment groups
were analyzed. Twenty one genes were statistically signif-
icantly differentially expressed (1.5-fold) by t-tests (data
not shown) and 14 genes by the REST method [Pfafﬂ
et al., 2002] (Table III and Additional File 1; File 1:
Supporting Information Table S2). The analysis showed
signiﬁcant increase in levels of cxcl-5 (30.0-fold), cxcl1
(7.0-fold), ccl2 (4.2-fold), ccl22 (3.4-fold), ccl7 (3.8-fold),
ccr4 (2.1-fold), and cytokine tumor necrosis factor (TNF,
1.8-fold) in lung tissues of mice treated with nanoTiO2.
Expression of interleukin-6, interleukin 1 beta, and IFN
gamma did not change. Overall, 14 transcripts that were
signiﬁcantly differentially expressed with FC > 1.5 as
measured by the microarray were validated using the
PCR arrays. Eleven of them are in agreement with the
results of the microarray.
Hepatic GeneExpression
We analyzed liver mRNA from the same mice and
found differential expression of 11 genes (FDR P-value
< 0.05); however, these expression changes were modest;
the largest change was a 1.6-fold downregulation of ‘‘simi-
lar to hepatocellular carcinoma-associated gene TD26.’’
The other 10 genes had fold changes below 1.2. The DNA
microarray data are available through the NCBI (http://
www.ncbi.nlm.nih.gov/geo/), GSE 19487. Overall ranking
of all genes according to fold change demonstrated that
gene expression was relatively unchanged in the livers.
GlobalMiRNAExpressionChanges
Agilent arrays containing 567 mouse probes were used
to examine changes in miRNA following exposure to
nanoTiO2. The data are available through the NCBI
(http://www.ncbi.nlm.nih.gov/geo/), GSE 19487. Fifty-ﬁve
miRNAs were signiﬁcantly altered by nanoTiO2 exposure
following FDR-adjustment (Table IV). The levels of six
miRNAs were increased by more than 1.5-fold; the only
downregulated miRNAs were miR-92a (1.3-fold) and
miR-223 (1.4-fold)). Real time RT-PCR analysis con-
ﬁrmed the upregulation of miR-449a, miR-1, and miR-
135b (Fig. 1B).
DISCUSSION
Short term or chronic exposure to nanoTiO2 particles by
inhalation or instillation has revealed that nanoTiO2
particles induce a complex pulmonary response that poten-
tially involves alterations in signaling cascades and associ-
ated expression of numerous genes and proteins [Lee et al.,
1985; Bermudez et al., 2002; Bermudez et al., 2004;
Warheit and Frame, 2006]. Changes in gene expression are
presumed to occur in response to exposure and in the early
stages of disease development, and thus lead to the down-
stream biological outcome. MiRNAs are proposed to be
one of the mechanisms regulating mRNA and protein lev-
els following toxicant exposure [Hudder and Novak, 2008;
Taylor and Gant, 2008], and thus are potentially important
mediators of toxic outcome. Concurrent analysis of
mRNAs and miRNAs is a powerful approach to explore
the direct response of the genome to toxicant exposure.
We have recently reported the developmental and neu-
rological effects of surface-coated nanoTiO2 particles
[Hougaard et al., 2010]. Pregnant mice were exposed for
1 hr daily for 11 consecutive days to 42.4 6 2.9 (SEM)
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TABLE III. Results of Pathway-Speciﬁc PCR Array (Mouse
Inﬂammatory Cytokines and Receptors)
Gene name P value Fold change
a
Chemokine (C-X-C motif) ligand 1 (Cxcl1) 0.000 7.00
Chemokine (C-C motif) ligand 2 (Ccl2) 0.000 4.20
Chemokine (C motif) receptor 1 (Xcr1) 0.000 1.80
Chemokine (C-X-C motif) ligand 5 (Cxcl5) 0.010 30.00
Secreted phosphoprotein 1 (Spp1) 0.010 2.00
Chemokine (C-C motif) ligand 6 (Ccl6) 0.021 1.90
Complement component 3 (C3) 0.021 1.70
Chemokine (C-C motif) ligand 22 (ccl22) 0.021 3.40
Chemokine (C-C motif) receptor 4 (Ccr4) 0.021 2.20
Chemokine (C-C motif) ligand 3 (ccl3) 0.024 2.20
Chemokine (C-C motif) ligand 12 (Ccl12) 0.026 2.00
Chemokine (C-C motif) ligand 9 (Ccl9) 0.028 1.70
Tumor necrosis factor (Tnf) 0.041 1.80
Chemokine (C-C motif) ligand 7 (Ccl7) 0.048 4.00
aAverage fold change compared with matched controls.
TABLE IV. MiRNA Results
Probe FDR P value Fold change
a
mmu-miR-449a 0.000 2.81
mmu-miR-1 0.000 1.92
mmu-miR-135b 0.000 1.83
mmu-miR-133b 0.004 1.59
mmu-miR-144 0.008 1.53
mmu-miR-21 0.000 1.52
mmu-miR-133a 0.018 1.39
mmu-miR-34b-5p 0.000 1.33
mmu-miR-193 0.048 1.29
mmu-miR-34c 0.000 1.28
mmu-miR-141 0.001 1.28
mmu-miR-33 0.003 1.26
mmu-miR-342-3p 0.000 21.25
mmu-miR-92a 0.007 21.26
mmu-miR-720 0.016 21.28
mmu-miR-223 0.001 21.39
aAverage fold change compared with matched controls.
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3 suspended nanoTiO2 particles via inhalation from
gestational day 8–18. The mice that failed to conceive
were sacriﬁced 5 days following the exposure. These
mice (nonpregnant adult) exhibited evidence of pulmo-
nary inﬂammation by analysis of cell counts in BALF. In
this study, we characterize the global mRNA and miRNA
response in the lungs of the nonpregnant adult mice, to
provide insight into the molecular mechanisms contribut-
ing to this effect. We also analyze global hepatic mRNA
response to the inhaled nanoTiO2. We demonstrate altera-
tions in pulmonary mRNA levels in pathways that are
consistent with the observed and predicted effects of par-
ticle exposure and also in line with the observed pheno-
type. We also report perturbation of several miRNAs in
the lungs of these mice. In contrast, gene expression was
relatively unaffected in the livers of the same mice.
PulmonaryInflammation
Analysis of different cell counts in BALF revealed an
increase in the total number of neutrophils, supporting the
presence of pulmonary inﬂammation, 5 days following
nanoTiO2 exposure in mature female mice from this study
[Hougaard et al., 2010]. Long-term pulmonary inﬂamma-
tion following inhalation of nanoTiO2 has previously been
documented in both mouse and rat models [Bermudez
et al., 2004; Ma-Hock et al., 2009; van Ravenzwaay
et al., 2009]. For example, studies have demonstrated
increased inﬁltration of neutrophils 2 weeks following
inhalation of 100 mg/m
3 mixed anatase and rutile nano-
TiO2 for 6 hrs/day for 5 days [Ma-Hock et al., 2009; van
Ravenzwaay et al., 2009]. Similarly, mice exposed to 10
mg/m
3 nanoTiO2 for 6 hrs/day, 5 days/week for 13 weeks
showed persistent increases in the number of neutrophils
following a 52 day recovery period [Bermudez et al.,
2004]. These studies, along with the data presented here,
suggest that nanoTiO2-induced pulmonary inﬂammation is
characterized by neutrophil inﬁltration.
This study also supports previous work demonstrating
that surface-treated nanoTiO2 particles are inﬂammogenic.
For example, intratracheal instillation of surface-treated
(alumina or alumina and amorphous silica) nanoTiO2
caused pulmonary inﬂammation in rats [Warheit et al.,
2005]. High doses of silanized hydrophobic ultraﬁne TiO2
instilled into rats resulted in increased lung toxicity [Pott
et al., 1998]. Mild inﬂammatory changes were noted in
rats instilled with low doses of silanized nanoTiO2 [Rehn
et al., 2003]. Similar inﬂammogenic responses were
observed in several other studies using ultraﬁne nonsur-
face-modifed nanoTiO2 both in vitro and in vivo [Baggs
et al., 1997; Drumm et al., 1999; Bermudez et al., 2002;
Bermudez et al., 2004; Renwick et al., 2004; de Haar
et al., 2006]. The extent of inﬂammation observed in this
study is in line with the overall calculated mass of nano-
TiO2 deposited in the pulmonary region (72.5 lg with a
surface area of 77.6 cm
2). Differential cell count analysis
of BALF revealed that 43% of the cells were neutrophils
[Hougaard et al., 2010]. This ﬁnding is in close agreement
with a previous experiment where mice exposed by instil-
lation to nanoTiO2 with a surface area of 50 cm
2 exhib-
ited 45% neutrophils in BALF [Oberdorster et al., 2005b].
A linear correlation between the total number of neutro-
phils in BALF and particle surface area was noted in
mice exposed for 24 hrs to ﬁve different types of nano-
particles, including the nanoTiO2 studied in this study
(Saber et al., personal communication). Similar relation-
ships between surface area and total number of neutro-
phils has also been reported by Tran et al. [Tran et al.,
2000]. Taken together, these studies demonstrate that
nanoTiO2 exposure promotes proinﬂammatory activities
across a wide range of doses, necessitating an understand-
ing of the molecular pathways involved in this response.
mRNAExpressionProfiling
Global transcriptional proﬁling of lung samples from
adult female mice exposed to nanoTiO2 revealed signiﬁcant
differential expression of several inﬂammation modulators.
Inhalation exposure to 42.4 6 2.9 (SEM) mg/m
3 nanoTiO2
for 1 hr every day for 11 consecutive days induced signiﬁ-
cant changes in the mRNA levels of several chemokine
genes. These include ccl2 (MCP-1 alpha), cxcl1 (keratino-
cyte cell-derived chemokine, KC), cxcl5 (epithelial cell-
derived neutrophil activating peptide ENA78), ccl22 (mac-
rophage-derived chemokine), ccl7 (monocyte chemotactic
protein 3, MCP3), ccl9/MIP1 gamma, and ccl3 (monocyte
inﬂammatory protein, MIP-1 alpha). These genes partici-
pate in the modulation of chemotaxis, inﬁltration of neutro-
phils, and epithelial proliferation. Because it is difﬁcult to
interpret the biological relevance of small fold changes of
individual genes, we emphasize changes in pathways and
groups of genes (i.e., pathways, and Gene Ontology molec-
ular functions and biological processes) in our discussion
below. When many genes that interact together to carry out
a biological function are perturbed, this is more likely to be
biologically relevant than an individual gene within that
family. Thus, the gene expression changes we observed col-
lectively provide molecular insight into the ﬁndings on
inﬂammation described earlier.
Neutrophil sequesteration is a critical event during pul-
monary inﬂammation and involves multiple steps includ-
ing the following: Increased production of chemokines
and cell adhesion molecules, and enhanced interactions
between cells. Cxcl1, macrophage inﬂammatory protein
22 (MIP2), and cxcl5 are the major chemokines for neu-
trophil recruitment and accumulation in mouse lungs.
Cxcl1 and MIP2 are produced predominantly by the inﬁl-
trating myeloid cells (macrophages and neutrophils) and
increases in their levels in response to a stimulant are
rapid and transient. In contrast, cxcl5 is produced by resi-
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vated levels of cxcl5 persist for days during lung inﬂam-
mation. Preferential and persistent induction of cxcl5 in
resident cells may be important in establishing cellular
communication between myeloid cells and resident cells,
which is required for initiation, maintenance and resolu-
tion of an inﬂammatory process [Jeyaseelan et al., 2005].
We observed high levels of cxcl5 5 days following
the last exposure in this study. This ﬁnding indicates
epithelial cell activation and may suggest continued lung
injury and persistent pulmonary inﬂammation.
Increased expression of ccl3, cxcl5, and cxcl1 has been
shown following nanoTiO2 exposure in several in vivo
mouse models; these ﬁndings were associated with the de-
velopment of pulmonary inﬂammation, granulomas, em-
physema, and pulmonary host defense [Driscoll et al.,
1993; Park et al., 2010; Rossi et al., 2010]. Disregulation
of inﬂammatory pathways following inhalation of nano-
TiO2 has also been shown by Chen et al. using a DNA
microarray approach [Chen et al., 2006]. These authors
used small ( 6,000 clones) ‘‘home-made’’ cDNA micro-
arrays to show that a single intratracheal instillation of
0.1 mg nanoTiO2 (rutile, uncoated pure particles of 19–21
nm in size) caused severe pulmonary inﬂammation with
alterations in genes involved in several pathways that
overlap with this work (chemokines and coagulation com-
plement cascade). Chemotaxis and immune response path-
ways, and Th1 and 2 type cytokines were also differen-
tially regulated in the BALF of mice treated with a single
intratracheal dose of 20 mg/kg nanoTiO2 (P25, primary
particle size 20 nm) 14 days after the last exposure [Park
et al., 2009]. In many of the aforementioned studies, com-
paratively high doses of particles were directly deposited
into the lungs of the animals by intratracheal instillation.
In this study, mice were exposed using a biologically rele-
vant exposure route to a relatively low dose of nanoTiO2
(mimicking the occupational scenario in terms of the total
mass administered) and similar changes in gene expres-
sion proﬁles were noted despite differences in doses and
time points. In contrast to our data and the studies
described earlier, Rehn et al. [2003] reported no signs of
inﬂammation in rats exposed to a range of occupationally
relevant low doses of surface-treated nanoTiO2. Discrep-
ancies between studies may be due to the targeted analy-
sis of speciﬁc markers of inﬂammation and endpoints
(e.g., total protein and BAL cells) applied by Rehn et al.
[2003] compared with analysis of the entire transcriptome.
Many nanotoxicological studies obtain data from a single
endpoint representative of a particular mechanism of
action, focusing on speciﬁc sets of genes or even a single
pathway. The drawback of this approach is that the mech-
anism of action must be known beforehand; moreover,
the expected phenotype or the physiological change may
not be apparent in the very low dose range. Global gene
expression proﬁles provide a snapshot of multiple cellular
processes operating in a single experiment without prior
knowledge of the mechanism of action. It is particularly
suitable to identifying early molecular changes predictive
of eventual pathological outcome. Thus, we demonstrate
that global gene expression signatures support the
observed phenotypes for exposure to nanoTiO2 that
response can be measured in the low-dose range, and the
results obtained can be used to provide insight into the
molecular mechanisms operating in response.
Pulmonary response to nanoTiO2 also causes increase
in levels of genes in the acute phase response pathway
(Table II) including Saa1, Saa3, C3, complement compo-
nents 1s (C1s), 3ar1 (C3ar1), 1qb (C1qb), 1r (C1r), and
1rb (C1rb). Moreover, several other acute phase proteins
exhibited fold changes >1.5-fold with unadjusted P-val-
ues < 0.05. These include C- reactive protein, ﬁbrinogen,
coagulation factor II, mannose binding protein, albumin,
apoAI, apoAII, and a2-hs-glycoprotein (regulator of SAA)
(Table II). The complement cascade includes 30 proteins
(some of which are enzymes), cofactors, inhibitors, and
membrane-associated proteins. These molecules act in
host defense by promoting phagocytosis and inﬂamma-
tion, which can activate the complement cascade resulting
in chemotaxis and pulmonary inﬂammation. Acute-phase
proteins have been used as biochemical markers of dis-
ease for numerous inﬂammatory processes. Induction of
acute phase response has previously been observed in
rodents following particle exposure. Saa is a generic
name for a family of apolipoproteins [Meek and Benditt,
1986] synthesized in response to activated monocyte/mac-
rophage-released cytokines such as IL-1 and IL-6 [Gana-
pathi et al., 1988; Jiang et al., 1995; Jensen and White-
head, 1998]. Although the liver is the major site of syn-
thesis of Saa [Morrow et al., 1981; Lowell et al., 1986],
extrahepatic tissues including lung, spleen, adrenal gland,
and others have been shown to express varying levels of
individual members of Saa genes in response to different
inﬂammatory stimuli [Meek and Benditt, 1986]. In this
study, Saa genes (1 and 3) were strongly induced in the
lungs of mice exposed to nanoTiO2. The increase in Saa3
mRNA levels was much greater (5.9-fold) than Saa1 (2.8-
fold). Corresponding protein levels of Saa3 were also
changed in lung tissue homogenates of the treated group
(Supporting Information Fig. S2B) but no change was
observed for Saa1. Previous work has demonstrated that
Saa genes are induced in mouse lung in response to dust
and lipopolysaccharide (LPS) [Meek and Benditt, 1986;
Andre et al., 2006; Park et al., 2010]. In keeping with this
study, while injection of LPS resulted in increased mRNA
levels of all three Saa genes in liver, Saa3 was predomi-
nantly expressed in lungs. Similarly, the largest increase
in Saa3 mRNA levels was noted in mouse lungs after
ultraﬁne particle exposure [Andre et al., 2006].
Select upregulation of Saa3 and associated proteins, to-
gether with increased gene expression of a suite of cyto-
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suggests a critical role for Saa3 in nanoTiO2-induced pul-
monary inﬂammation/immune response. In premetastatic
lungs, Saa3 induction by chemoattractants such as
S100A8 plays a role in myeloid cell accumulation and
acts as a positive feedback regulator for chemoattractant
secretion [Hiratsuka et al., 2008]. In this study, S100A8
mRNA levels were decreased compared with the controls
(21.9-fold; unadjusted P-value < 0.05) in the treatment
group suggesting the involvement of a different regulatory
mechanism for Saa3. Although the cytokines IL-1, IL-6,
and TNF play a role in the expression of Saa genes, only
TNF was marginally upregulated in our model. We also
observed a marginal increase in TNF protein in BAL cells
as well in lung tissue homogenates by protein arrays (data
not shown), suggesting a possible role for TNF in Saa3
expression in response to nanoTiO2.
Several chemokines (cxcl5, cxcl1, and ccl3) and com-
ponents of the acute phase pathway (Saa3, c3) measured
in this study are rapidly induced in response to acute
injury or stress. However, the increase in their expression
levels is transient and falls rapidly once the stimulus is
removed or the injury is repaired. Thus, high and persist-
ing levels of these acute stressors 5 days after the last ex-
posure may reﬂect the magnitude of the injury and indi-
cate initiation of secondary pathological conditions.
In addition to conﬁrming the response of these path-
ways, we also found a dramatic increase in polymeric Ig
receptor (PIgr, 2.0-fold), solute carrier family 26, mem-
ber 4 (Slc26a4, 3.4-fold), and lipocalin 2 (Lcn2, 3.3-fold).
These genes are involved in mucosal immune defense.
NADPH oxidase organizer 1 (Noxo1), a gene associated
with antimicrobial defense [Flo et al., 2004; Schneeman
et al., 2005; Nakao et al., 2008], was also upregulated by
3-fold. We also found upregulation of the proinﬂamma-
tory genes Vanin-1 and 3 (Vnn-1,23, 2.6- and 1.9-fold,
respectively) in nanoTiO2-exposed lungs [Nitto et al.,
2008]. Thus, our results conﬁrm strong activation of pul-
monary immune and inﬂammation in response to nano-
TiO2 inhalation.
Despite signiﬁcant upregulation of several genes associ-
ated with acute phase, inﬂammation and immune response
in lung, the hepatic transcriptome of these mice was unaf-
fected. These ﬁndings agree with our previous report
showing few changes in hepatic transcription in mice
exposed by inhalation to doses of carbon black and diesel
exhaust that caused substantial pulmonary inﬂammation
[Saber et al., 2009]. The results suggest that systemic
effects in liver are secondary to pulmonary inﬂammation
and may not require gene expression.
NanoTiO2Exposure
Based on the exposure conditions, each animal in this
study was exposed to  840 lg of nanoTiO2 (11 days
3 1 hr/day 3 40 mg/m
3 3 0.0018 m
3 inhaled/hr 5
0.840 mg/animal). It is predicted that the majority of
nanosized particles deposit in the lung once inhaled. The
deposition of particles in the lungs depends on the size of
the particles. In this study, the mass of the airborne frac-
tion contained predominantly micrometer-sized particles.
On the basis of the deposition model described by Jacob-
sen et al. [2009], we expected a deposition of 72.5 lgi n
the pulmonary region, 48 lg in the tracheobronchial
region, 356 lg in the gastrointestinal tract, and 267 lgo f
nanoTiO2 in the skull. Hence, with an average lung
weight of 274 mg, the estimated deposited pulmonary
dose amounts to 265–439 mg/kg nanoTiO2 corresponding
to 112–159 mg nanotitanium (Ti)/kg in the lung, depend-
ing on whether pulmonary or bronchopulmonary regions
are considered. Detection in lung tissue using ICPMS
revealed 38 mg/kg Ti in the lungs [Hougaard et al.,
2010], indicating that although signiﬁcant clearing of the
lungs had taken place during the 16 days after the ﬁrst ex-
posure, considerable amounts of nanoTiO2 were still pres-
ent 5 days postexposure. This corresponds to 24–34% of
predicted nanoTiO2 deposition in lungs. Our results are in
agreement with Rossi et al. [2010], who exposed mice
by inhalation to 10 mg/m
3 of surface-coated nanoTiO2
(40 nm) for a total of 32 hrs. They showed  60% of the
deposited nanoTiO2 was cleared over a 4-week period
[Rossi et al., 2010]. This suggests that the small particle
size leads to alveolar deposition with subsequent slow
clearing [Oberdorster, 1995]. Depending on the particle
size, some of the inhaled nanoTiO2 is also expected to be
deposited in the nasal region. Approximately 90% of 1
nm, 20–30% of 5–10 nm, and less than 10% of 20 nm
particles deposited in the nasopharyngeal region. A small
fraction of the total particle mass deposited in the nasal
region has previously been shown to be efﬁciently trans-
located to olfactory bulb in brain through axonal transport
via olfactory neurons [Oberdorster et al., 2002, 2004].
However, particles deposited in the nasal region of the
respiratory system would be quickly cleared either by
blowing the nose, sneezing, or by efﬁcient mucociliary
transport mechanism. As such, we have not assessed the
deposition of particles in the upper respiratory tract and
hence their uptake by the central nervous system. Since
particles in the nasal region are rapidly cleared, and since
we have measured the gene expression changes 5 days
after the last exposure, we believe that the contribution of
nasally deposited particles to overall outcome in the pres-
ent model is likely to be minimal.
The dose administered in this study corresponds to the
highest occupational exposure limit for dust (in terms of
total mass administered, 5 mg/m
3 during an 8 hr working
day) in Denmark. Thus, this study used a relatively low,
occupationally relevant exposure regime in combination
with robust and conservative statistical analysis of a sufﬁ-
ciently large sample size of animals. However, one could
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(as observed in this study), along with the dose used, lung
overburden has occurred. Although the dose rate was
high, the deposited dose is only a fraction of what would
result in overload (i.e., slower motility of alveolar macro-
phages and impaired mucociliary clearance). Moreover,
the particles in this study were surface coated with Si, Zr,
and Al. It has been shown that surface-coated nanoTiO2
are more toxic than benign pure particles of nanoTiO2
[Rossi et al., 2010]. Although we did not test the possibil-
ity that surface coatings (Si, Al, and Zr) themselves con-
tributed to the toxicity, it is documented in the literature
that Si, Zr, and Al are less toxic when administered on
their own [Rossi et al., 2010], suggesting that the slower
clearance and retention of smaller size particles in the
lung tissue could be the reason behind observed pulmo-
nary response. Here, we conﬁrm that nanoTiO2 inhalation
results in changes in proinﬂammatory, immune response
and complement cascade-related genes that persist for rel-
atively long periods of time after the ﬁnal exposure. The
observed fold changes for any particular gene in our study
were much lower than the other reports, which may be
due to the lower doses used, the differences in exposure
set up, or the types of particles used. However, a large
portion of these changes were validated with quantitative
RT-PCR and RT-PCR arrays. Thus, we argue that the pul-
monary response observed in our study is likely due to
the highly toxic nature of the particles and not lung over-
burden.
Although the mice in this study were exposed to doses
near the occupational exposure limit for dust in Denmark
in terms of total mass administered, it might be argued
that the dose is high if the hours of exposure are consid-
ered (i.e., delivered in 1 hr vs. exposure over an 8 hr
work day). Genomic tools have not been extensively used
to understand nanoassociated toxicity. Using animals that
exhibit an inﬂammatory response following the exposure,
this work was initiated to establish proof of principle that
genomic tools can be applied to characterize the effects
of nanoparticles at relatively low doses and reveal the
molecular perturbations that persist at this time point that
contribute to the observed phenotype. However, the
observed overall response at the transcriptional level must
be investigated in studies incorporating multiple doses,
time points, and different types of nanoTiO2, to truly dis-
sect the mechanism of acute exposure and distinguish
between immediate early effects and persistent effects.
Thus, multiple time points and doses were not conducted
in this study, but will be the subject of future work.
MiRNAExpressionProfiling
Despite a dramatic increase in Saa1 gene transcript lev-
els, we did not see a correlated increase in its protein syn-
thesis. Similarly, in contrast to the  5-fold transcriptional
increase of Saa3 mRNA, Saa3 protein was increased by
only 2-fold. One mechanism that controls translation of
proteins involves targeted translational repression by miR-
NAs. Thus, to address the observed discrepancies between
the transcription and protein expression proﬁles and to
explore the potential role of miRNAs in mitigating
mRNA and translation in response to particle exposure,
we analyzed global changes in pulmonary miRNA expres-
sion using DNA microarrays. Total RNA from lung tis-
sues of control and exposed mice was used. The analysis
revealed 55 statistically signiﬁcant changes; 16 were
altered by more than 1.2-fold and six had fold changes
>1.5 (Table IV). Because an individual miRNA may tar-
get hundreds of mRNAs, a small change in a miRNA
may have signiﬁcant repercussions on transcription and
translation. As such, we explored changes both above and
below the 1.5-fold threshold.
Some of the miRNAs that are altered in response to
nanoTiO2 have been implicated in inﬂammation and
immune response. For example, upregulation of miR-21
and downregulation of miR-1 has recently been observed
in IL-13 transgenic mice with allergic airway inﬂamma-
tion [Lu et al., 2009]. MiR-21 is expressed by inﬂamma-
tory leukocytes in asthmatic lung [Jin et al., 2008], hema-
topoietic cells [Landgraf et al., 2007], and in macrophages
and dendritic cells [Lu et al., 2009]. MiR-21 is induced in
murine macrophages following LPS challenge [Lu et al.,
2009], all suggesting a critical association for miR-21 in
inﬂammation and immune response. MiR-1 levels
increase during myocardial differentiation of mouse em-
bryonic stem cells [Takaya et al., 2009]. Farraj et al.
[2010] have shown that miR-1 and miR-21 are signiﬁ-
cantly downregulated in the myocardium of rats exposed
to synthetic particulate matter. Other miRNAs affected by
nanoTiO2 exposure have been linked to a cancer pheno-
type. For example, differential expression of miR-135b is
found in human colon cancer samples [Sarver et al.,
2009] and miR-449a is associated with antitumor activity
in prostate cancer cells [Noonan et al., 2009].
Analysis by qRT-PCR conﬁrmed the higher levels of
miR-449a (fold six), miR-1 (2.6-fold), and miR-135b (60-
fold) in this study (Fig. 1B) but not the suppression of
miR-223 and miR-92a. Analysis of curated targets in Tar-
Base (http://diana.cslab.ece.ntua.gr/tarbase/) did not reveal
any known targets of miR-449a or miR-135b. As such,
we searched for mRNA targets of miR-135b and miR-
449a using the target-prediction softwares TargetScan and
Pictar. Predicted targets for miR-135b (TargetScan or Pic-
tar) that were differentially expressed (downregulated)
included the following: checkpoint suppressor1, runt
related transcription factor 2 (runx2), and phosphodiester-
ase 8b. Predicted targets of miR-449a that were differen-
tially expressed included the following: lymphoid
enhancer-binding factor 1 (lef1) and Kit ligand. Runx2
and lef1 are the downstream targets of WNT signaling
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mon function in regulating WNT signaling. However, it
appears that the effect of the observed 6- and 60-fold
induction of miR-449a and miR-135b on transcript levels
of their predicted targets is negligible. There may be sev-
eral reasons to explain the lack of changes in target
mRNAs. First, the genes targeted by miR-449a and miR-
135b in response to particle exposure may be different
than the ones predicted in silico. Second, the majority of
the genes changing in response to nanoTiO2 in our model
are acutely induced and therefore the magnitude of their
induction is expected to be 10–100-fold higher immedi-
ately following the exposure. Therefore, even if some of
these genes are directly targeted by the miRNAs at the
transcriptional level, their suppression may not be below
those of control levels. Third, it is also possible that the
predominant mode of action for these miRNAs is through
translational repression.
Currently, the causes and consequences of miRNA
response following exposure to nanoTiO2 are unknown.
However, changes at the transcriptional level of several tar-
get genes are implicated in acute phase and inﬂammatory
response. Thus, miR-1, miR-135b, and miR-449a may play
a role in these biological processes. We have recently con-
ﬁrmed induction of miR-135b in other inﬂammatory mod-
els including particle-induced inﬂammation (Halappanavar
et al., unpublished data). The induction of several inﬂam-
matory chemokines and acute phase components is well
characterized in response to particle exposure, including
nanoTiO2 (as described in detail earlier). However, the pos-
sibility that these molecular pathways could be under the
direct control of miRNAs that play a role in particle-
induced response is yet to be demonstrated. We hypothe-
size that some of the genes, including the Saa family and
chemokines, are the direct targets of miR-135b and that
miR-135b could be acting to resolve the inﬂammation pro-
cess. A similar hypothesis was also proposed by Jardim
et al. [2009]. These authors suggest that disruption in
miRNA expression in response to diesel exhaust particles
(DEP) in human airway epithelial cells could be implicated
in modulation of the inﬂammatory process induced by
DEP. Further characterization of miR-135b responsive
genes and their role in particle-induced pulmonary response
is being carried out in our laboratory to determine the bio-
logical relevance of these changes.
The miRNA ﬁeld is still developing in parallel with more
powerful tools to study their expression and activity. At
present, a number of published studies describe changes in
the expression of several miRNAs in diseases (reviewed in
[Sun and Tsao, 2008]) or in certain biological processes
in vitro and in vivo [Bueno et al., 2008; Lynam-Lennon
et al., 2009]. However, there are very few studies that have
characterized changing mRNA and miRNA proﬁles in tar-
get tissues in vivo in response to toxic substances (reviewed
in [Lema and Cunningham, 2010]). To our knowledge, this
is the ﬁrst report on particle-induced pulmonary miRNA
changes. Integration of gene and miRNA expression pro-
ﬁles with reports examining multiple endpoints at the mo-
lecular, cellular, tissue, and physiological levels will be
very useful in understanding the toxicity of particles in the
context of the whole organism. Further studies incorporat-
ing acute, subchronic, and chronic doses with different
types of nano TiO2 particles and multiple time points are
needed to validate our ﬁndings.
CONCLUSIONS
This work demonstrates the induction of acute phase
reactants, chemoattractants, immune and host defense
genes following exposure to occupationally relevant levels
of surface-coated titanium dioxide nanoparticles via a bio-
logically relevant exposure route. These ﬁndings are in
keeping with the expected health outcome of chronic
nanoparticle exposure, and the changes persist for up to 5
days following exposure. In parallel with perturbation of
these genes, speciﬁc miRNAs are also induced in the
lungs in response to nanoTiO2. The role of miRNAs in
response to particle-induced lung injury is now under
investigation in our laboratory.
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